The role of the molecular tumor board: learnings from the ROME trial.

Marchetti P, Curigliano G, Westphalen CB, Biffoni M, Lonardi S, Scagnoli S, Fornaro L, Guarneri V, De Giorgi U, Ascierto PA, Blandino G, D'Amati G, Aglietta M, Cremolini C, Conte P, Crimini E, Ceracchi M, Pisegna S, Verkhovskaia S, Bordonaro R, Bracarda S, Butturini G, Del Mastro L, DeCensi A, Fabbri A, De Galitiis F, Fenocchio E, Gori S, Metro G, Pessino A, Pozzessere D, Puglisi F, Tamberi S, Zambelli A, Marino D, Capoluongo E, Cappuzzo F, Cerbelli B, Giannini G, Malapelle U, Mazzuca F, Nuti M, Pruneri G, Simmaco M, Strigari L, Tonini G, Savarese A, Adamo V, Quaresmini D, Tagliaferri P, Damiano P, Urbini B, Bengala C, Zaffignani E, Pinto C, Tosoni A, Buffoni L, Maiello E, Mucciarini C, Russo A, Berardi R, Lombardi G, Piancastelli A, Masi G, Bonanno L, Vanella V, Mannozzi F, Martini N, Botticelli A

Open source

DOI: 10.1038/s41698-026-01386-1
Published: 2026 Apr 10
Container: NPJ precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-026-01386-1,
  title = {The role of the molecular tumor board: learnings from the ROME trial.},
  author = {Marchetti P and Curigliano G and Westphalen CB and Biffoni M and Lonardi S and Scagnoli S and Fornaro L and Guarneri V and De Giorgi U and Ascierto PA and Blandino G and D'Amati G and Aglietta M and Cremolini C and Conte P and Crimini E and Ceracchi M and Pisegna S and Verkhovskaia S and Bordonaro R and Bracarda S and Butturini G and Del Mastro L and DeCensi A and Fabbri A and De Galitiis F and Fenocchio E and Gori S and Metro G and Pessino A and Pozzessere D and Puglisi F and Tamberi S and Zambelli A and Marino D and Capoluongo E and Cappuzzo F and Cerbelli B and Giannini G and Malapelle U and Mazzuca F and Nuti M and Pruneri G and Simmaco M and Strigari L and Tonini G and Savarese A and Adamo V and Quaresmini D and Tagliaferri P and Damiano P and Urbini B and Bengala C and Zaffignani E and Pinto C and Tosoni A and Buffoni L and Maiello E and Mucciarini C and Russo A and Berardi R and Lombardi G and Piancastelli A and Masi G and Bonanno L and Vanella V and Mannozzi F and Martini N and Botticelli A},
  year = {2026},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-026-01386-1},
  url = {https://doi.org/10.1038/s41698-026-01386-1}
}

RIS

TY  - JOUR
TI  - The role of the molecular tumor board: learnings from the ROME trial.
AU  - Marchetti P
AU  - Curigliano G
AU  - Westphalen CB
AU  - Biffoni M
AU  - Lonardi S
AU  - Scagnoli S
AU  - Fornaro L
AU  - Guarneri V
AU  - De Giorgi U
AU  - Ascierto PA
AU  - Blandino G
AU  - D'Amati G
AU  - Aglietta M
AU  - Cremolini C
AU  - Conte P
AU  - Crimini E
AU  - Ceracchi M
AU  - Pisegna S
AU  - Verkhovskaia S
AU  - Bordonaro R
AU  - Bracarda S
AU  - Butturini G
AU  - Del Mastro L
AU  - DeCensi A
AU  - Fabbri A
AU  - De Galitiis F
AU  - Fenocchio E
AU  - Gori S
AU  - Metro G
AU  - Pessino A
AU  - Pozzessere D
AU  - Puglisi F
AU  - Tamberi S
AU  - Zambelli A
AU  - Marino D
AU  - Capoluongo E
AU  - Cappuzzo F
AU  - Cerbelli B
AU  - Giannini G
AU  - Malapelle U
AU  - Mazzuca F
AU  - Nuti M
AU  - Pruneri G
AU  - Simmaco M
AU  - Strigari L
AU  - Tonini G
AU  - Savarese A
AU  - Adamo V
AU  - Quaresmini D
AU  - Tagliaferri P
AU  - Damiano P
AU  - Urbini B
AU  - Bengala C
AU  - Zaffignani E
AU  - Pinto C
AU  - Tosoni A
AU  - Buffoni L
AU  - Maiello E
AU  - Mucciarini C
AU  - Russo A
AU  - Berardi R
AU  - Lombardi G
AU  - Piancastelli A
AU  - Masi G
AU  - Bonanno L
AU  - Vanella V
AU  - Mannozzi F
AU  - Martini N
AU  - Botticelli A
PY  - 2026
JO  - NPJ precision oncology
DO  - 10.1038/s41698-026-01386-1
UR  - https://doi.org/10.1038/s41698-026-01386-1
ER  -

APA

P, M., G, C., CB, W., M, B., S, L., S, S., L, F., V, G., U, D. G., PA, A., G, B., G, D., M, A., C, C., P, C., E, C., M, C., S, P., S, V., R, B., S, B., G, B., L, D. M., A, D., A, F., F, D. G., E, F., S, G., G, M., A, P., D, P., F, P., S, T., A, Z., D, M., E, C., F, C., B, C., G, G., U, M., F, M., M, N., G, P., M, S., L, S., G, T., A, S., V, A., D, Q., P, T., P, D., B, U., C, B., E, Z., C, P., A, T., L, B., E, M., C, M., A, R., R, B., G, L., A, P., G, M., L, B., V, V., F, M., N, M., & A, B. (2026). The role of the molecular tumor board: learnings from the ROME trial.. NPJ precision oncology. https://doi.org/10.1038/s41698-026-01386-1

Source records

pubmed · retrieved 2026-09-25T22:51:45.099Z